# Photonamic acquires MolecuLight's clinical oncology business

Photonamic GmbH & Co. KG acquired the clinical oncology business of Toronto-based MolecuLight. The two businesses will form a subsidiary called SBI ALApharma Canada, combining MolecuLight's fluorescence imaging technology with Photonamic's 5-ALA contrast agent.

- Type: Acquisition
- Announced: 2019-08-15
- Where: Toronto, Canada, Canada
- Status: completed
- Products: fluorescence imaging technology, 5-ALA contrast agent
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MolecuLight Inc.](https://endata.com/companies/41343.md) (target)
- [Photonamic](https://endata.com/companies/41390.md) (acquirer)

## Sources

- [betakit.com](https://betakit.com/moleculights-oncology-business-acquired-by-germany-based-photonamic/), 2019-08-15: "We are thrilled to announce the acquisition of our clinical oncology business by such a valued and strategic partner as Photonamic."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.